ACLY induces the resistance to MAPK inhibition by activating acetyltransferase P300 to acetylate the histone at the MITF locus, thus promoting the transcription of the MITF-PGC1 α axis and ultimately facilitating melanoma growth (84). Here, PPARGC1A is linked to melanoma.